Jeffs Roger's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Sep 2, 2025
- Accession no.
- 0001231615-25-000008
- Filed
- Sep 2, 2025
- Trade date
- Sep 2, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.67M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jeffs RogerCIK 0001231615 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | SSaleDisposed | −13,464 | $123.68F3 | −$1,665,227.52 | 57,510 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $121.30 and $124.60.
Referenced by the price of 1 transaction in Table I.